Financials

  • Market Capitalization 121.57 M
  • Employee 226
  • Founded 1999
  • CEO James Corbett
  • Website www.avitamedical.com
  • Headquarter Delaware, United States
  • FIGI BBG00TD18T43
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.98
Price to sales ratio
1.34

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3818
MXCT
MaxCyte, Inc. - Common Stock
1.38 USD+3.76%+7.81%+21.05%-38.94%147.83 M USD
3825
CVRX
CVRx, Inc. - Common Stock
5.43 USD0.00%-4.06%+3.63%-26.72%144.09 M USD
3952
XAIR
Beyond Air, Inc. - Common Stock
7.49 USD+1683.33%+1564.44%+1871.05%+145.57%107.94 M USD
3968
HYPR
Hyperfine, Inc. - Class A Common Stock
1.05 USD-3.67%-16.67%-24.46%+32.91%104.23 M USD

Frequently asked questions about Avita Medical, Inc. - Common Stock

What is the Avita Medical, Inc. - Common Stock stock price today?

The current price of Avita Medical, Inc. - Common Stock (RCEL) is 3.95. Over the past 24 hours, the stock has changed by -2.71%. Follow the RCEL chart for real-time price dynamics.

What is the stock ticker of Avita Medical, Inc. - Common Stock?

Avita Medical, Inc. - Common Stock trades under the ticker RCEL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Avita Medical, Inc. - Common Stock stock going up?

RCEL has changed by -24.04% over the last week, 0.00% over the last month, and -32.82% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Avita Medical, Inc. - Common Stock net income for the last quarter?

Avita Medical, Inc. - Common Stock reported net income of -10.61 M for the last quarter. The previous quarter showed -11.62 M, which means net income changed by +8.69%.

How many employees does Avita Medical, Inc. - Common Stock have?

As of the latest available data, Avita Medical, Inc. - Common Stock has 226 employees. Workforce size can provide additional context about the company's scale and operations.

What is Avita Medical, Inc. - Common Stock EBITDA?

Avita Medical, Inc. - Common Stock EBITDA is -8.18 M, and its EBITDA margin is -42.47%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Avita Medical, Inc. - Common Stock stock?

You can buy Avita Medical, Inc. - Common Stock (RCEL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Avita Medical, Inc. - Common Stock stock?

Investing in Avita Medical, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RCEL chart and related analysis on metatrader.com as part of your research.

Avita Medical, Inc. - Common Stock

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

News